UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1951
TIC Solutions Inc
TIC
$2.2B
| $2.31M | ﹤0.01% |
285,538
+14,338
| +5% | +$121K |
2025 Q2
4 quarters
|
|
1952
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.9B
| $2.31M | ﹤0.01% |
19,386
-12,770
| -40% | -$1.46M |
2025 Q4
2 quarters
|
|
1953
Lucid Motors
LCID
$1.3B
| $2.3M | ﹤0.01% |
343,423
-3,634
| -1% | -$23.5K |
2021 Q4
18 quarters
|
|
1954
USA Today Co
TDAY
$948M
| $2.29M | ﹤0.01% |
268,362
-170,157
| -39% | -$1.28M |
2024 Q3
7 quarters
|
|
1955
Tandem Diabetes Care
TNDM
$1.34B
| $2.29M | ﹤0.01% |
151,847
-16,646
| -10% | -$291K |
2018 Q4
30 quarters
|
|
1956
LGI Homes
LGIH
$986M
| $2.29M | ﹤0.01% |
35,980
+4,060
| +13% | +$194K |
2017 Q4
34 quarters
|
|
1957
MannKind Corp
MNKD
$1.06B
| $2.29M | ﹤0.01% |
537,134
-695,508
| -56% | -$2.26M |
2023 Q1
13 quarters
|
|
1958
Rio Tinto
RIO
$138B
| $2.28M | ﹤0.01% |
24,039
| – | – |
2025 Q4
2 quarters
|
|
1959
Novavax
NVAX
$1.69B
| $2.28M | ﹤0.01% |
242,229
-19,037
| -7% | -$171K |
2020 Q2
24 quarters
|
|
1960
Koppers
KOP
$794M
| $2.27M | ﹤0.01% |
50,668
-8,234
| -14% | -$337K |
2022 Q3
15 quarters
|
|
1961
Liquidity Services
LQDT
$1.4B
| $2.27M | ﹤0.01% |
58,135
-2,201
| -4% | -$77.9K |
2021 Q4
18 quarters
|
|
1962
NPK International
NPKI
$951M
| $2.27M | ﹤0.01% |
142,373
+12,740
| +10% | +$192K |
2023 Q4
10 quarters
|
|
1963
MediaAlpha
MAX
$612M
| $2.26M | ﹤0.01% |
180,171
-340
| -0.2% | -$3.21K |
2024 Q2
8 quarters
|
|
1964
Capital Group Growth ETF
CGGR
$25.9B
| $2.26M | ﹤0.01% |
47,910
| – | – |
2025 Q4
2 quarters
|
|
1965
Dimensional Emerging Markets Value ETF
DFEV
$2.15B
| $2.26M | ﹤0.01% |
52,921
| – | – |
2026 Q1
1 quarter
|
|
1966
Chime Financial
CHYM
$10.8B
| $2.26M | ﹤0.01% |
+110,129
| New | +$2.14M |
2026 Q2
0 quarters
|
|
1967
Garmin
GRMN
$56.4B
| $2.25M | ﹤0.01% |
9,473
-1,386,208
| -99% | -$337M |
2025 Q4
2 quarters
|
|
1968
Concentrix
CNXC
$1.89B
| $2.25M | ﹤0.01% |
100,381
-26,155
| -21% | -$682K |
2021 Q1
21 quarters
|
|
1969
Harrow
HROW
$1.11B
| $2.24M | ﹤0.01% |
52,737
+1,770
| +3% | +$65.8K |
2024 Q3
7 quarters
|
|
|
WSR
1970
DELISTED
Whitestone REIT
WSR
| $2.24M | ﹤0.01% |
117,895
+8,686
| +8% | +$163K |
2025 Q4
2 quarters
|
|
1971
iShares MSCI USA Min Vol Factor ETF
USMV
$24.1B
| $2.23M | ﹤0.01% |
23,160
-3,100
| -12% | -$294K |
2025 Q4
2 quarters
|
|
1972
Southside Bancshares
SBSI
$940M
| $2.23M | ﹤0.01% |
63,442
-947
| -1% | -$31.4K |
2013 Q2
52 quarters
|
|
1973
Willdan Group
WLDN
$1.12B
| $2.22M | ﹤0.01% |
28,039
+6,496
| +30% | +$553K |
2025 Q2
4 quarters
|
|
1974
Preferred Bank
PFBC
$1.25B
| $2.21M | ﹤0.01% |
20,827
+2,032
| +11% | +$195K |
2017 Q1
37 quarters
|
|
1975
AdaptHealth
AHCO
$804M
| $2.21M | ﹤0.01% |
211,807
-6,427
| -3% | -$71.8K |
2021 Q2
20 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.